Targeted delivery of highly toxic anti-cancer drug to brain tumors
(University of Houston) University of Houston biomedical researcher Sheeren Majd is reporting the development and testing of a new nano-carrier as a potential treatment to deliver highly toxic medicine to glioblastomas, the most common and aggressive form of primary brain tumors.
Source: EurekAlert! - Biology - Category: Biology Source Type: news
More News: Biology | Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Nanotechnology | Neurology | Toxicology